The Stanford University School of Medicine has received $90 million from Ludwig Cancer Research on behalf of its founder, Daniel K. Ludwig, to support the school's innovative work in cancer stem cells, which are believed to drive the growth of many cancers.

New research by scientists at the University of Exeter has shown that cells demonstrate remarkable flexibility and versatility when it comes to how they divide–a finding with potential links to the underlying causes of many cancers.

Chemists develop new way to kill cancer cells resistant to the chemotherapy drug cisplatin.

It appears tiny and inconsequential enough, but the "super mouse" — created by researchers at the University of Kentucky Markey Cancer Center some six years ago — has spawned plenty of new research into preventing and/or treating many types of cancer.

Through research, testing, care, and education, The University of Texas MD Anderson Cancer Center, located in Houston, Texas, takes an integrative approach to cancer. We speak with Pramila Sood, lab administrator for the Department of Laboratory Medicine, about the unique management issues at the Center.

Traditional approaches for research into tumor formation have revolved around histological classification